Ultragenyx Pharmaceutical Inc. sell StockNews.com
Start price
29.11.23
/
50%
€35.60
Target price
29.11.24
-
Performance (%)
26.97%
End price
30.11.24
€45.20
Summary
This prediction ended on 30.11.24 with a price of €45.20. The prediction closed with a disappointing performance of 26.97%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.970% | 2.970% | -52.074% |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% |
Comments by StockNews_com for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten